Navigation Links
DIASTAT™ Anti-CCP

ProductsDIASTAT™ Anti-CCP
Company Inverness Medical Innovations
Item DIASTAT™ Anti-CCP
Features 
  • Diagnosis of RA in early synovitis patients
  • Differentiation of RA from other inflammatory arthritides
  • Differential diagnosis of RA from other connective tissue diseases such as erosive systemic lupus erythematosus
  • Confirmation of diagnosis in seronegative RA
  • Potential to identify patients who will develop a more severe form of RA at disease onset
  • Potential to monitor therapeutic effectiveness
Description A new highly sensitive and specific second-generation peptide-based test, DIASTAT Anti-CCP* is an ELISA based on the detection of autoantibodies against the cyclic citrullinated peptide (CCP) containing modified arginine residues in human serum or plasma. Enabling early and accurate diagnosis of RA, the Anti-CCP assay provides an additional tool in the diagnosis and management of patients with RA.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Wampole PreVue B. Burgdorferi Antibody Detection Assay
2. Wampole Impact Rubella Slide Test
3. Wampole Impact Syphilis RPR Test Kit
4. Wampole Impact Syphilis RPR® Test Kit
5. Wampole Rubella-plus Test Kit
6. Cogent Microbial Luminescence System
7. BD Affirm™ VPIII Microbial Identification Test
8. Silicone Oil Cannula System - 20 Gauge
9. Silicone Oil Cannula System - 19 Gauge
10. SuperVu Galilean System
11. KOWA nonmyd 7 / VK-2 Digital Imaging System
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products:
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: